Encompass Health Corporation (EHC) Stock Overview
Explore Encompass Health Corporation’s financial performance, market position, analyst ratings, and future outlook.
Encompass Health Corporation (EHC)
Key Financials
Key Financials
Market Cap
12.3B
P/E Ratio
19.78
EPS (TTM)
$5.84
ROE
0.25%
EHC Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Encompass Health Corporation (NYSE: EHC) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of A, Encompass Health Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of EHC on the NYSE shows an RSI of 58.15, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $123.95 for the NYSE listing.
Key metrics behind Encompass Health Corporation's NYSE-traded stock include a P/E ratio of 19.78 and a market capitalization of 12.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EHC on the NYSE.